" Current and future public health is characterized by the increase of chronic and degenerative diseases, corresponding to the worldwide ageing of the population. The increasing prevalence of these conditions together with the long incubation period of the chronic diseases and the continuous technological innovations, offer new opportunities to develop strategies for early diagnosis. It is an important task of public health to critically assess the promises and the pitfalls of screening strategies. In this perspective, this MOOC will detail the background concepts of early diagnosis, the methods to assess the effectiveness and the efficiency of screening programs, the tools available of scaling up a local program, etc. In a second part of the course, current and future trends in screening in several conditions will be presented, including cancer, cardiovascular and metabolic disease, prenatal and neonatal conditions (including genetic screening), and communicable disease. By the end of this MOOC, students should be able to develop a public health perspective on screening and to actively participate to the evaluation of screening strategies. This MOOC has been prepared under the auspices of the Ecole romande de santé publique (www.ersp.ch) by Prof. Fred Paccaud, MD, MSc, Head of the Institute of Social and Preventive Medicine in Lausanne (www.iumsp.ch), in collaboration with Professor Antoine Flahaut, MD, PhD, head of the Institute of Global Health, Geneva (www.unige.ch/medecine/isg)."
Ce MOOC, réalisé en anglais sous les auspices de l'ERSP avec la collaboration de l'Institut de santé globale de Genève, est publiquement accessible sur la plateforme Coursera. Deux modalités d'accès sont possibles, une gratuite sans aucun suivi et une permettant l'obtention d'un certificat à la fin. Le prix de pour la voie "Certifiante" est de 49$.
Le cours est structuré en 7 modules qui peuvent être suivis à un rythme d'un par semaine en dediant de 1 à 3 heures par semaine :
Introduction Prof. Antoine Flahault (Head, Institute of global health, Geneva) and Prof. Fred Paccaud (Head, Institute of social and preventive medicine, Lausanne), on the behalf of the Ecole Romande de Santé Publique.
Concepts and metrics Idris Guessous, MD, PhD, Unit of population epidemiology, Department of community health, Geneva, and Division of chronic diseases, Institute of social and preventive medicine, Lausanne
Policies and evaluation Jean-Luc Bulliard, PhD, epidemiologist, Division of chronic diseases, Institute for social and preventive medicine, Lausanne
Cardometabolic conditions Arnaud Chiolero, MD, PhD, Division of chronic diseases, Institute of social and preventive medicine, Lausanne
Cancer Elisabetta Rapiti, MD, Geneva cancer registry, Institute of global health, Geneva Antoine Flahault, MD, PhD, Head, Institute of global health, Geneva
Neuropsychiatric conditions Emiliano Albanese, MD, PhD, University Psychiatric Hospital, Geneva
Prenatal, perinatal and genetic conditions Murielle Bochud, MD, PhD, head of the Division of chronic diseases, Institute of social and preventive medicine, Lausanne
Screening in low and middle-income countries Catherine Sauvaget, MD, PhD, International Agency for Research on Cancer (IARC), Lyon Pascal Bovet, MD, MPH, Division of chronic diseases, Institute of social and preventive medicine, Lausanne
Conclusion Fred Paccaud, MD, MSc, Head, Institute of Social and Preventive Medicine, Lausanne